Top compounds associated with response to CCL4L2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.08
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.08
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.058 0.08
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.11 0.08
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.058 0.09
mRNA PD173074 GDSC1000 pan-cancer AAC -0.062 0.09
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.069 0.09
mRNA TAK-715 GDSC1000 pan-cancer AAC -0.057 0.09
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.055 0.09
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.058 0.09
Download CSV